BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 23, 2026
Home » Newsletters » BioWorld Asia

BioWorld Asia

March 9, 2011

View Archived Issues

IMI Facilitates Innovation, New Projects Funded with $239.1M

LONDON – The Innovative Medicines Initiative (IMI) announced eight new projects with total funding of €172 million, (US$239.1 million) in the next stage of the €2 billion program to redesign the drug discovery and development process and rebuild the competitiveness of Europe's biopharmaceutical sector. (BioWorld International) Read More

Bavarian Nordic Seeks Cancer-Related Viruses

LONDON – Danish vaccines specialist Bavarian Nordic AS is to lead a DKK90 million (US$16.9 million) national project to discover viruses and bacteria that are involved in initiating cancer and which could form the basis of preventative vaccines. Read More

Down Syndrome Blood Test Enters Wider Analysis

LONDON – A new and precise method of diagnosing Down syndrome prenatally using a maternal blood sample could be rolled out to clinics within a couple of years, the researchers who developed it anticipate. Read More

Shire Dumps Renovo's Scar Drug After Phase III Failure

Read More

Arsanis' Founders Convince Forward-Looking 'A' Investors

Read More

Abcodia Taps UK Biobank for Biomarker Discovery

Read More

Other News To Note

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 22, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • Nankai University and Accendatech present new majusculamide D derivatives

    BioWorld Science
    Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
  • Evaxion shares data from characterization of EVX-04

    BioWorld Science
    Evaxion A/S has developed EVX-04, an AI-designed DNA vaccine encoding 1β endogenous retroviruses (ERVs)-derived antigenic fragments to induce broad...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing